Car-t is amazing - currently as per previous announcements works on blood cancers - with approx 80% Orr in trials and 50% complete response. Approved in the US for 2 indications, I understand as at early 2019 for b-cell lymphoma and b-cell lymphoblastic leukemia - however sustained remissions are anticipated in approx 40% patients (.https://www.ascopost.com/issues/september-10-2019/update-on-fda-approved-car-t-cell-gene-therapy-for-b-cell-lymphomas/ ) the current 27% complete response from PTX200 in r/r patients In AML is imho under appreciated by the market - with enrolments the trial still ongoing and everyday an announcement regarding another CR (life saved) imminent; in this context
- Forums
- ASX - By Stock
- PTX200
Car-t is amazing - currently as per previous announcements works...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $9.791K | 244.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 521085 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 82865 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 521085 | 0.039 |
4 | 1070000 | 0.038 |
8 | 396864 | 0.037 |
2 | 575000 | 0.036 |
5 | 389304 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 82865 | 1 |
0.041 | 236982 | 2 |
0.042 | 650000 | 4 |
0.043 | 421000 | 2 |
0.045 | 278101 | 4 |
Last trade - 12.01pm 13/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |